(R)-2-(6-(3-AMINOPIPERIDIN-1-YL)-3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YLMETHYL)-4-FLUOROBENZAMIDE
UNII MN553E7FBX
Substance Identification & Data
This profile provides standardized clinical and technical data for (r)-2-(6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl)-4-fluorobenzamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MN553E7FBX.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1938080-44-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H22FN5O3 AKNPUJHLPMLIQG-CYBMUJFWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (r)-2-(6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl)-4-fluorobenzamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.